EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Opioid Antagonists for Hedonic Liberation—Not All Is Over

Farid Shagiakhmetov, Inna Shamakina, Viktor Kokhan, Evgeny Krupitsky

Future Pharmacology · 02.05.2026 · 6 (2) · 26

DOI: 10.3390/futurepharmacol6020026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Pharmacology, online erschienen am 02.05.2026. Verfasst von Farid Shagiakhmetov und 3 weiteren Autor:innen. Die Arbeit nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent Phase 3 clinical trials of selective kappa-opioid (KOP) receptor antagonists aticaprant and navacaprant failed to demonstrate sufficient clinical efficacy in treatment-resistant depression (TRD). This highlights a critical gap in current strategies that target opioid-mediated hedonic suppression. We propose two hypotheses to explain these setbacks: (1) neutral antagonists are inherently ineffective in blocking constitutively active KOP receptor hyperactivation and (2) the nociceptin opioid (NOP) receptor provides functional redundancy that compensates for KOP receptor blockade. Gaining insights from paralogous compensation in drug-resistant tumors, we argue for shifting from selective opioid antagonists to dual KOP/NOP receptor blockers to meaningfully improve reward function. This concept provides a theoretical framework for overcoming clinical resistance where selective KOP targeting with neutral antagonists has failed. Thus, we advocate for the development of opioid inverse agonists (such as nor-BNI, CAS: 105618-26-6), pan-antagonists (such as AT-076, CAS: 1657028-64-2), and combinations of selective blockers.

Zitieren

APA

Shagiakhmetov, F., Shamakina, I., Kokhan, V., & Krupitsky, E. (2026). Opioid Antagonists for Hedonic Liberation—Not All Is Over. Future Pharmacology, 6(2), 26. https://doi.org/10.3390/futurepharmacol6020026

Vancouver

Shagiakhmetov F, Shamakina I, Kokhan V, Krupitsky E. Opioid Antagonists for Hedonic Liberation—Not All Is Over. Future Pharmacology. 2026;6(2):26. doi:10.3390/futurepharmacol6020026

BibTeX
@article{Shagiakhmetov2026,
  author = {Shagiakhmetov, Farid and Shamakina, Inna and Kokhan, Viktor and Krupitsky, Evgeny},
  title = {Opioid Antagonists for Hedonic Liberation—Not All Is Over},
  journal = {Future Pharmacology},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {26},
  doi = {10.3390/futurepharmacol6020026}
}
Kostenlos starten →